SINGAPORE · HSA PRE-MARKET CONSULTATION

HSA Pre-market Consultation (PMC): How Overseas R&D Teams Bring New-Product Questions to HSA

When a new product is headed for Singapore, the first thing an R&D team has to settle is usually not a registration form but three premises: how the intended use is defined, whether the existing studies support the intended performance claims, and whether the next round of validation is aimed at the right regulatory question. If those are unclear, more documents do not bring the team closer to an executable registration plan.

HSA’s Pre-market Consultation (PMC) scheme exists for exactly these questions, and MediPass provides preparation and coordination support for overseas R&D companies: framing the issues, organising the material, coordinating the booking and pre-meeting preparation, and carrying the outcome into the registration work that follows. The consultation itself is accepted and scheduled by HSA; it is not a product evaluation and does not guarantee approval.

You do not need a Singapore company to request an HSA consultation

HSA opens development consultations to device developers and researchers and pre-submission consultations to parties preparing a Singapore registration; bookings are made online through HSA’s SHARE system, and having a Singapore company is not a precondition. MediPass’s value is not a channel that only an agent can enter, but a well-prepared cross-border conversation: the R&D team keeps its direct role in the technical discussion while we manage the agenda, document versions and communication rhythm.

Meeting preparation and the later appointment of a local registrant are separate matters. One consultation does not mean a licence holder has been appointed; if the team decides to proceed to registration afterwards, the scope is confirmed separately under our Singapore registration services.

Development or pre-submission consultation: which one

TypeStage and purposeScope per sessionHSA fee
Development ConsultationRegulatory questions during development: device claims, safety and performance studies, risk management, clinical trial designOne device, or a group of devices used together as a system; up to 2 hoursS$530 per device per consultation
Pre-submission ConsultationFeedback on the completeness and appropriateness of the dossier before a registration application is submittedOne product registration application; up to 1 hourS$210 per application per consultation

Pre-submission consultation does not apply to Class A devices (which are exempt from product registration), but Class A devices may use a development consultation. The choice follows the question at hand: if the team is still deciding which studies to run next, start with development questions; if the technical solution is stable and the issue is how the existing dossier supports this application, approach it as pre-submission preparation. Do not pick a type by duration or fee alone, and do not try to fit several years of product roadmap into one meeting.

Booking and meeting logistics: timing, documents, attendees

  • Booking window: at least 30 days and at most 5 months ahead, online through SHARE.
  • Documents: uploaded at booking and complete at least 30 days before the meeting; incomplete material can lead to rescheduling or cancellation.
  • Attendees: HSA recommends no more than 5.
  • Rescheduling and refunds: one reschedule per booking, subject to availability; fees are non-refundable.

So the internal plan should not start with “grab a date”; work backwards from when the material will be ready. More attendees are not better either: prioritise the people who can explain the key technology, study design and registration strategy, and decide who leads and who supports. Whether remote participation is possible is confirmed by HSA case by case.

Keep HSA fees and service scope separate

The S$530 / S$210 above are HSA’s government consultation fees, shown separately from MediPass’s service fee; check HSA’s current fee schedule before booking. MediPass’s coordination scope is agreed before the project starts and typically covers product and question framing, a document index, pre-meeting preparation and rehearsal, booking and pre-meeting communication, and a post-meeting action list. Whether additional studies, testing, translation, the formal registration or licence-holding services are included is stated explicitly in the proposal.

How MediPass helps a team prepare useful questions

Write down the product and the boundary of the discussion first

We start from the product brief: who uses it, on which patients or specimens, how the output affects a medical decision, where the hardware/software boundary lies and which version the discussion is about. We also separate confirmed facts, the company’s preliminary view and open points: “intended for home use” and “home-user study completed” must be written as two different statements. Marking what is not yet done helps the discussion more than covering gaps with a general “complies with international standards”.

Turn broad doubts into questions HSA can respond to

“Can our product be approved?” rarely yields specific advice. A more useful structure is: what the product facts are, what approach the company intends to take, what support already exists and which single uncertainty remains. We help turn Chinese technical material into clear English meeting questions, each tied to the relevant document.

A hypothetical example: an analysis-support software is to be extended from specialist use to general outpatient clinics. Rather than asking only “do we need more data”, the team should first show how users, inputs, outputs and risks differ between the two settings, then present the validation it proposes to add and ask HSA to discuss its suitability. That is how a meeting result feeds the next design step instead of ending in a general answer.

Carry the feedback into R&D and registration plans

We help turn the discussion into a question log and an action list that separates points answered, points needing more material and points needing further confirmation, with owners and the next deliverable. Minutes must reflect the discussion accurately: the company’s understanding is not rewritten as HSA having approved a design, and “no objection raised” is not recorded as formal endorsement. If the intended use or approach changes later, the premises of the earlier conclusions are rechecked.

Frequently asked questions about HSA pre-market consultation

We already have FDA or CE approval. Do we still need a consultation?

It depends on whether there is a Singapore-specific question worth clarifying. If the product and dossier route are already clear, there is no need to book a meeting just to “see an officer”; if the intended use, applicability of evidence or approach has changed, list the specific doubts first and then judge the value of a consultation.

Can the R&D lead skip the meeting and let the agent speak?

It depends on the topic. Where algorithms, study design or clinical interpretation are involved, direct participation by the technical lead usually clarifies details better; a coordinator can organise the discussion but should not answer unverified technical facts on the team’s behalf.

What should we prepare before contacting MediPass?

A short product description, the current development stage, the target use, an overview of existing data, and the three to five questions you most want answered. How full technical files are shared and kept confidential can be arranged once the service scope is confirmed.

Official references

  1. HSA: Pre-market Consultation (PMC) Scheme — consultation types, booking window, documents and rescheduling rules
  2. HSA: Medical device fees — development consultation S$530, pre-submission consultation S$210

This article is a preparation guide; it does not replace HSA’s case-specific advice or the applicable regulations. Official procedures and fees are as published at the time of application.

Leave a Comment

Your email address will not be published. Required fields are marked *

Chat on WhatsAppWhatsApp 咨询